Effects of ABO Matching of Platelet Transfusions in Critically Ill Children

Autor: Jhuma Sankar, Anil Sapru, Laura Watkins, Jon Lillie, Anna Camporesi, Ofer Schiller, Andrew Meyer, Oliver Karam, ELENA CAVAZZONI, Fabrizio Chiusolo, Antonio Perez Ferrer, James Killinger, Kenneth Remy, Jesus Lopez-Herce, Mara L Leimanis Laurens, Edward Vincent S. Faustino, Kevin Kuo, Hari Krishnan Kanthimathinathan, Srinivas Murthy, Mark Peters, Arun Saini, Shubhi Kaushik, Andy Wen, Angela Aramburo
Přispěvatelé: Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE), Grazioli, Serge, Pediatric Surgery
Rok vydání: 2019
Předmět:
Male
medicine.medical_treatment
Critical Care and Intensive Care Medicine
Platelet Count/statistics & numerical data
Primary outcome
Interquartile range
hemic and lymphatic diseases
and the P3T Investigators
Platelet
Prospective Studies
Prospective cohort study
Child
Pediatric
ddc:618
Hematology
Platelet Transfusion/adverse effects/methods
Intensive Care Units
Blood Grouping and Crossmatching/methods
Blood
Child
Preschool

Female
medicine.medical_specialty
congenital
hereditary
and neonatal diseases and abnormalities

Adolescent
pediatrics
Pediatric Critical Care Blood Research Network (BloodNet)
Critical Illness
Platelet Transfusion
Nursing
Intensive Care Units
Pediatric

Paediatrics and Reproductive Medicine
Clinical Research
ABO blood group system
Internal medicine
parasitic diseases
medicine
Humans
Pediatric/statistics & numerical data
Preschool
ABO compatibility
Mechanical ventilation
business.industry
Critically ill
Platelet Count
Infant
Newborn

Infant
Transfusion Reaction
Newborn
Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
biological factors
Platelet transfusion
Blood Grouping and Crossmatching
P3T Investigators
Pediatrics
Perinatology and Child Health

Transfusion Reaction/epidemiology
sense organs
business
Zdroj: Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 20(2), e61-e69. LIPPINCOTT WILLIAMS & WILKINS
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, vol 20, iss 2
Pediatric Critical Care Medicine, Vol. 20, No 2 (2019) pp. e61-e69
Pediatric Critical Care Medicine, 20(2), E61-E69. Lippincott Williams & Wilkins
ISSN: 1529-7535
DOI: 10.1097/pcc.0000000000001779
Popis: OBJECTIVES: To determine if transfusing ABO compatible platelets has a greater effect on incremental change in platelet count as compared to ABO incompatible platelets in critically ill children.DESIGN: Secondary analysis of a prospective, observational study. Transfusions were classified as either ABO compatible, major incompatibility, or minor incompatibility. The primary outcome was the incremental change in platelet count. Transfusion reactions were analyzed as a secondary outcome.SETTING: Eighty-two PICUs in 16 countries.PATIENTS: Children (3 d to 16 yr old) were enrolled if they received a platelet transfusion during one of the predefined screening weeks.INTERVENTIONS: None.MEASUREMENTS AND MAIN RESULTS: Five-hundred three children were enrolled and had complete ABO information for both donor and recipient, as well as laboratory data. Three-hundred forty-two (68%) received ABO-identical platelets, 133 (26%) received platelets with major incompatibility, and 28 (6%) received platelets with minor incompatibility. Age, weight, proportion with mechanical ventilation or underlying oncologic diagnosis did not differ between the groups. After adjustment for transfusion dose, there was no difference in the incremental change in platelet count between the groups; the median (interquartile range) change for ABO-identical transfusions was 28 × 10 cells/L (8-68 × 10 cells/L), for transfusions with major incompatibility 26 × 10 cells/L (7-74 × 10 cells/L), and for transfusions with minor incompatibility 54 × 10 cells/L (14-81 × 10 cells/L) (p = 0.37). No differences in count increment between the groups were noted for bleeding (p = 0.92) and nonbleeding patients (p = 0.29). There were also no differences observed between the groups for any transfusion reaction (p = 0.07).CONCLUSIONS: No differences were seen in the incremental change in platelet count nor in transfusion reactions when comparing major ABO incompatible platelet transfusions with ABO compatible transfusions in a large study of critically ill children. Studies in larger, prospectively enrolled cohorts should be performed to validate whether ABO matching for platelet transfusions in critically ill children is necessary.
Databáze: OpenAIRE